Free Trial

Genpact (NYSE:G) Given "Hold (C)" Rating at Weiss Ratings

Genpact logo with Computer and Technology background

Genpact (NYSE:G - Get Free Report)'s stock had its "hold (c)" rating reiterated by research analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

A number of other research analysts also recently issued reports on the company. Needham & Company LLC boosted their price target on Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a report on Friday, August 8th. Deutsche Bank Aktiengesellschaft assumed coverage on Genpact in a research note on Thursday, July 17th. They set a "hold" rating and a $47.00 target price for the company. Wall Street Zen downgraded Genpact from a "buy" rating to a "hold" rating in a research note on Friday, September 5th. Mizuho increased their price objective on Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research note on Tuesday, July 1st. Finally, JPMorgan Chase & Co. reduced their price objective on Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a research note on Wednesday, August 20th. Three analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $52.29.

Check Out Our Latest Stock Analysis on G

Genpact Price Performance

Shares of G stock opened at $40.66 on Wednesday. Genpact has a fifty-two week low of $37.82 and a fifty-two week high of $56.76. The firm has a market capitalization of $7.09 billion, a price-to-earnings ratio of 13.51, a PEG ratio of 1.40 and a beta of 0.89. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.53 and a current ratio of 1.53. The stock's 50-day simple moving average is $43.11 and its 200-day simple moving average is $44.74.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, August 7th. The business services provider reported $0.88 EPS for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.23 billion. Genpact had a return on equity of 22.15% and a net margin of 10.92%.Genpact's revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.79 earnings per share. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. As a group, equities analysts forecast that Genpact will post 3.21 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, SVP Piyush Mehta sold 76,902 shares of the stock in a transaction on Friday, September 12th. The stock was sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the completion of the transaction, the senior vice president directly owned 134,880 shares in the company, valued at approximately $5,743,190.40. This represents a 36.31% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Balkrishan Kalra sold 55,000 shares of the firm's stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $43.36, for a total value of $2,384,800.00. Following the transaction, the chief executive officer owned 295,246 shares of the company's stock, valued at $12,801,866.56. This trade represents a 15.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 3.07% of the company's stock.

Hedge Funds Weigh In On Genpact

Hedge funds and other institutional investors have recently bought and sold shares of the company. Cornerstone Planning Group LLC acquired a new stake in Genpact in the 1st quarter valued at about $27,000. Richardson Financial Services Inc. acquired a new stake in shares of Genpact during the 1st quarter worth about $35,000. SVB Wealth LLC acquired a new stake in shares of Genpact during the 1st quarter worth about $41,000. Steph & Co. acquired a new stake in shares of Genpact during the 2nd quarter worth about $37,000. Finally, Huntington National Bank raised its position in shares of Genpact by 208.2% during the 2nd quarter. Huntington National Bank now owns 906 shares of the business services provider's stock worth $40,000 after acquiring an additional 612 shares in the last quarter. 96.03% of the stock is currently owned by hedge funds and other institutional investors.

About Genpact

(Get Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Analyst Recommendations for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Markets Are Sliding: Where to Find Opportunity
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines